McKay Tina B, Smith Matthew, Mueller Ariel, Li Haobo, Patel Pooja H, Freedman Isaac G, Qu Jason Z, Akeju Oluwaseun
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, EDW 410, Boston, MA, 02114, USA.
J Neurol. 2025 May 12;272(6):393. doi: 10.1007/s00415-025-13145-6.
Postoperative delirium is a significant complication in older adults undergoing cardiac surgery. This study investigated associations between serum amyloid beta (Aβ40, Aβ42), their ratio Aβ42/Aβ40 (AβR), and total tau (tTau) and postoperative delirium.
This analysis included participants aged ≥ 60 years undergoing elective cardiac surgery with cardiopulmonary bypass. Serum Aβ40, Aβ42 and tTau were measured before surgery and on postoperative day one using a digital immunoassay. The primary outcome was postoperative delirium, assessed twice daily for 3 days using the Confusion Assessment Method.
Postoperative delirium developed in 12% (38/312) of participants. In adjusted analyses examining preoperative biomarkers, the odds of postoperative delirium were independently associated with Aβ40 (OR 1.44 per standard deviation increase, 95% CI 1.06-1.98; p = 0.021), AβR (OR 0.65, 95% CI 0.42-0.99; p = 0.046), and tTau (OR 1.65, 95% CI 1.01-2.68; p = 0.045). Aβ42 was statistically significant only in unadjusted analyses (OR 1.43, 95% CI 1.00-1.88; p = 0.012). In adjusted analyses examining postoperative biomarkers, the odds of postoperative delirium were independently associated with Aβ42 (OR 1.60, 95% CI 1.08-2.37; p = 0.020) and tTau (OR 1.56, 95% CI 1.09-2.23; p = 0.015).
Aβ40, AβR, and tTau were associated with postoperative delirium in elderly patients undergoing elective cardiac surgery. These findings suggest that postoperative delirium may be linked to pre-existing vulnerabilities shared with neurodegenerative processes along the Alzheimer's disease spectrum, offering new insights into its underlying mechanisms and potential connection to long-term cognitive decline.
术后谵妄是接受心脏手术的老年人的一种重要并发症。本研究调查了血清淀粉样蛋白β(Aβ40、Aβ42)、其比值Aβ42/Aβ40(AβR)和总tau蛋白(tTau)与术后谵妄之间的关联。
本分析纳入了年龄≥60岁、接受择期体外循环心脏手术的参与者。术前及术后第1天采用数字免疫分析法检测血清Aβ40、Aβ42和tTau。主要结局为术后谵妄,采用意识模糊评估法每天评估2次,共评估3天。
12%(38/312)的参与者发生了术后谵妄。在检查术前生物标志物的校正分析中,术后谵妄的几率与Aβ40(每标准差增加的比值比为1.44,95%置信区间为1.06-1.98;p=0.021)、AβR(比值比为0.65,95%置信区间为0.42-0.99;p=0.046)和tTau(比值比为1.65,95%置信区间为1.01-2.68;p=0.045)独立相关。Aβ42仅在未校正分析中有统计学意义(比值比为1.43,95%置信区间为1.00-1.88;p=0.012)。在检查术后生物标志物的校正分析中,术后谵妄的几率与Aβ42(比值比为1.60,95%置信区间为1.08-2.37;p=0.020)和tTau(比值比为1.56,95%置信区间为1.09-2.23;p=0.015)独立相关。
Aβ40、AβR和tTau与接受择期心脏手术的老年患者术后谵妄有关。这些发现表明,术后谵妄可能与阿尔茨海默病谱系中神经退行性过程共有的既往易感性有关,为其潜在机制及与长期认知衰退的潜在联系提供了新的见解。